GLP-1R/GIPR agonist-1 sodium is the sodium salt form of GLP-1R/GIPR agonist-1. It acts as a dual agonist for the glucagon-like peptide-1 receptor (GLP-1R, EC50 = 0.57 nM) and the glucose-dependent insulinotropic polypeptide receptor (GIPR, EC50 = 0.75 nM). GLP-1R/GIPR agonist-1 sodium lowers blood glucose by mimicking the effects of endogenous hormones GLP-1 and GIP, enhancing insulin secretion, and inhibiting glucagon secretion. This compound is applicable in research on metabolic disorders such as diabetes, obesity, and non-alcoholic steatohepatitis (NASH).
Formula:
C220H334N55O69.xNa
Target:
Glucagon Receptor
* VAT and and shipping costs not included. Errors and price changes excepted
